×
Sign in
Menu
Home
Resources
Back To Top
×
Contact the Presenter
×
Add To Cart
×
Test
ESMO Virtual Congress 2020
Final Programme PDF
Advanced Search
14.09.2020
15.09.2020
17.09.2020
18.09.2020
19.09.2020
20.09.2020
21.09.2020
22.09.2020
23.09.2020
12.10.2020
13.10.2020
14.10.2020
15.10.2020
16.10.2020
17.10.2020
18.10.2020
EONS Satellite
Industry Satellite Symposium
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
00:00
Channel: On-Demand
09:00(14h 59m)
10x Genomics - Resolve cancer with single cell and spatial multiomics
09:00(14h 59m)
Advanced Accelerator Applications - Elucidate metastatic prostate cancer targets with radioligand therapy and molecular profiling: Advancing precision medicine in prostate cancer
09:00(14h 59m)
Advanced Accelerator Applications - Optimising NET treatment: The place of radioligand therapy
09:00(14h 59m)
Astellas - Improving advanced prostate cancer patients’ lives with early treatment intensification
09:00(14h 59m)
AstraZeneca - Current status and future directions for immunotherapy in hepatocellular carcinoma
09:00(14h 59m)
Bayer - Precision medicine in Real-world clinical practice: Perspectives from a multidisciplinary team
09:00(14h 59m)
Boehringer Ingelheim - Focus on NSCLC treatment options
09:00(14h 59m)
Bristol Myers Squibb - Exploring the current and evolving landscape in thoracic cancers
09:00(14h 59m)
Bristol Myers Squibb - Harnessing the Potential of the Immune System: Clinical Insights From Utilizing CTLA-4 Within a Dual I-O Approach in aRCC
09:00(14h 59m)
Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
09:00(14h 59m)
Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
15:33(1h 27m)
EONS Satellite - Eli Lilly/Eisai: Integrative medicine
12:02(1h 28m)
EONS Satellite - Ipsen: Patient reported outcomes in immuno-oncology in combination with TKI
13:31(1h 29m)
EONS Satellite - Merck MSD/Baxter: Digital health and self-management
10:04(1h 26m)
EONS Satellite - Roche: COVID-19 and cancer nursing
09:00(14h 59m)
F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
09:00(14h 59m)
F. Hoffmann-La Roche - Putting personalised healthcare at the heart of clinical practice
09:00(14h 59m)
F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
09:00(14h 59m)
Illumina - Comprehensive genomic profiling: A new paradigm in oncology
09:00(14h 59m)
Incyte Biosciences International Sàrl - Patient Centricity in Cholangiocarcinoma: A multidisciplinary discussion
09:00(14h 59m)
Ipsen - The today and tomorrow of systemic treatment for HCC
09:00(14h 59m)
Janssen - Advanced prostate cancer: How do we move forward in patient management?
09:00(14h 59m)
Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon
09:00(14h 59m)
Kite, a Gilead Company - Optimising the patients’ CAR T-cell journey
09:00(14h 59m)
Merck - The dynamic map of treatment for SCCHN: The optimal pathway for your patient (Commercial)
09:00(14h 59m)
MSD - Multiple immunotherapeutic options: Clinical decision making in advanced renal cell carcinoma and urothelial carcinoma
09:00(14h 59m)
MSD - New approaches, old barriers: Will cancer patients get access to the combinations and early treatments they need?
09:00(14h 59m)
MSD - Translating immuno-oncology biomarkers into clinical practice
09:00(14h 59m)
PeerVoice - Extending overall survival in nmCRPC while maintaining quality of life: Can we have it all?
09:00(14h 59m)
Pfizer Oncology - Building a new paradigm in prostate cancer
09:00(14h 59m)
Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
09:00(14h 59m)
Pfizer Oncology - The complete picture: Managing breast cancer in the real-world
09:00(14h 59m)
Pfizer Oncology - Treatment considerations in biomarker-driven NSCLC: Diagnostics and sequencing
09:00(14h 59m)
Pierre Fabre - BRAF V600E-mutant mCRC: Spotlight on the patient journey
09:00(14h 59m)
Pierre Fabre - Extending the reach of personalised care in HER2-positive breast cancer
09:00(14h 59m)
Servier - Can current treatment strategies for mCRC be further optimized?
09:00(14h 59m)
Servier - Joining efforts beyond first-line management in patients with metastatic pancreatic cancer
09:00(14h 59m)
Takeda - Oncogenic drivers in advanced NSCLC: Navigating an evolving landscape to optimize patient outcomes
09:00(14h 59m)
Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
×
Dialog
×
Sponsored Access
Access to the resources are offered to you by
ESMO Events